Purchase Order 75F40123P00272
Award Date 8/23/23
Potential Completion Date 2/19/24
Potential Value $51K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- The Department of Health and Human Services Food and Drug Administration awarded a $43,337.06 firm fixed price delivery order to Pacific Biosciences of California, Inc. under the agency's indefinite-delivery/indefinite-quantity contract 75F40121D00007. The delivery order is for the purchase of specific supplies and reagents for use with Pacific Biosciences' PacBio Sequel IIE long-read DNA/RNA sequencer to support the FDA's regulatory science programs. Performance will occur in Laurel, Maryland...
- The U.S. Food and Drug Administration awarded a $736,000 firm fixed-price definitive contract to Pacific Biosciences of California, Inc. for a real-time sequencer system with four one-year post-warranty maintenance option periods. The contract, awarded on September 3, 2019, with an ultimate completion date of December 11, 2024, is designated as a Total Small Business set-aside. Pacific Biosciences, a leading biotechnology company specializing in advanced DNA and RNA sequencing technologies, will...
- The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company...
- The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...
- This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
- The Food and Drug Administration awarded a $300,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for corrective, remedial repair, and preventive maintenance services on a high-throughput long-read sequencer system. The contract, awarded February 26, 2026, extends through February 28, 2030, and will be performed at the vendor's facility in Menlo Park, California. This award represents a continuation of FDA's established relationship with Pacific Biosciences, which...
- The Food and Drug Administration (FDA) awarded a firm-fixed-price service contract to Pacific Biosciences of California, Inc. for $314,960.99 to provide parts, labor, and preventative maintenance for a Sequel 2e long-read sequencer located in Berwyn Heights, MD. The service contract will cover annual inspections and priority repairs within three business days to maintain the sequencer and generate consistent, high-quality data to help the FDA resolve foodborne disease outbreaks. This award was...
- The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...
- The Department of Health and Human Services Food and Drug Administration awarded a $33,175 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, HiFi Express Template Prep Kit 2.0, Sequel Binding Kit 3.0, Sequel Sequencing Kit 3.0, and SMRT Cell 1M v3 LR Tray. The place of performance is Silver Spring, Maryland. The contract period runs from August 29, 2023 through March 30, 2024. As the prime...